GlobalData on MSN6d
FDA grants breakthrough status to J&J’s nipocalimab for SjD treatment
The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...
Pharmabiz6d
US FDA grants breakthrough therapy designation to Johnson & Johnson’s nipocalimab to treat adults living with moderate-to-severe Sjögren's disease
Spring House, Massachusetts Wednesday, November 13, 2024, 14:00 Hrs [IST] ...
manilatimes6d
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of ...
PMLiVE5d
J&J’s nipocalimab granted FDA breakthrough designation for Sjögren’s disease
Johnson & Johnson (J&J) has announced that its anti-FcRn antibody nipocalimab has become the first investigational therapy to ...
Vaxcyte provides regulatory updates on VAX-31 programs
Vaxcyte (PCVX) announced positive regulatory updates, including the United States Food and Drug Administration, FDA, clearance of the VAX-31 ...
Seeking Alpha6d
Ultragenyx: Ready For More Growth After Q3 Earnings Beat
Setrusumab (UX143) recently received the FDA's Breakthrough Therapy Designation (BTD) for osteogenesis imperfect following ...
Vaxcyte, Inc.: Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 -- -- VAX-31 Adult Indication: ...
WorkBoat4d
Coast Guard boat acquisitions and requests for proposal
Commander Noel Johnson, Chief of the Platform Division in the Office of Boat Forces, opened the International WorkBoat Show’s ...
Medindia5d
Neurologists Describe Early Detection of Alzheimer's Disease as 'Critical' for New Treatments
Alzheimer's disease is the most common cause of dementia in the elderly and is characterized by abnormal deposits of amyloid-beta and tau proteins in the brain. This disease has a ...
Zacks.com on MSN3d
Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback
The third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...